The inclusion criteria included documented diagnosis of AMI
through clinical and paraclinical tests, age of over 18 years, verbal
ability to communicate, knowledge of the Greek language,
absence of symptoms of AMI during the data collection (typical
and non-typical symptoms), haemodynamic stability during the
data collection (blood pressure measurements in normal ranges,
absence of arrhythmias or bradycardia), absence of a previous
history of AMI and diagnosed neurological disorders (Alzheimer’s
disease, other types of dementia, stroke).